IRM
42
-4
INTC
48
5
WY
51
-5
AMG
41
3
VRTX
62
-6
AAP
39
7
HCA
53
2
EQT
59
5
MCHP
41
-4
PRU
59
5
AN
54
2
HON
70
5
DNB
88
2
SO
55
-2
STZ
52
2
NRG
52
-5
NUE
62
-2
KHC
9
-8
WBA
53
6
AKAM
47
5
IRM
42
-4
INTC
48
5
WY
51
-5
AMG
41
3
VRTX
62
-6
AAP
39
7
HCA
53
2
EQT
59
5
MCHP
41
-4
PRU
59
5
AN
54
2
HON
70
5
DNB
88
2
SO
55
-2
STZ
52
2
NRG
52
-5
NUE
62
-2
KHC
9
-8
WBA
53
6
AKAM
47
5
Financhill
Back

Beam Therapeutics Stock Predictions

Yours Free! Top SIX AI Dividend Stocks Right Now

NO CREDIT CARD REQUIRED!
Buy
73

BEAM
Beam Therapeutics

Last Price:
27.95
Seasonality Move:
54.38%

7 Day Trial

ALL ACCESS PASS

$ 7

The Mysterious VC Firm Behind Nvidia's Secret Weapon

Details Here!

Beam Therapeutics Stock Forecast

  • Over the next 52 weeks, Beam Therapeutics has on average historically risen by 14.7% based on the past 4 years of stock performance.
  • Beam Therapeutics has risen higher in 1 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 25%
  • Is Beam Therapeutics Stock Undervalued?
    The current Beam Therapeutics [BEAM] share price is $30.38. The Score for BEAM is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
  • BEAM is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.

Will Beam Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Beam Therapeutics has on average historically risen by 14.7% based on the past 4 years of stock performance.

Beam Therapeutics Stock Rating

Buy
73
Beam Therapeutics (BEAM) is a Buy

Is Beam Therapeutics overpriced?

  • Beam Therapeutics has risen higher in 1 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 25%

Beam Therapeutics Stock Price History

Is BEAM stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BEAM is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
beamtx.com

52-Week Data

52-Week High:
49.50
52-Week Low:
18.85

Prediction Charts

Market Cap:
2.52B
Price in USD:
30.38
Volume:
1.77M
Beta:
1.79

Technical Analysis

SMA50:
24.35
SMA100:
25.17
SMA200:
26.81
52-Wk Change:
37.09%

Stock Predictions

  • Is Beam Therapeutics stock public?
    Yes, Beam Therapeutics is a publicly traded company.
  • What is the Beam Therapeutics stock quote today?
    The Beam Therapeutics stock price is 30.38 USD today.
  • How to buy Beam Therapeutics stock online?
    You can buy Beam Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-23 22.63 21.82 22.76 21.76
Oct-24 22.04 22.09 22.14 21.14
Oct-25 22.18 21.55 22.32 21.50
Oct-28 21.90 22.35 22.74 21.68
Oct-29 22.35 22.15 22.35 21.85
Oct-30 21.93 22.50 22.70 21.79
Oct-31 22.61 21.92 22.61 21.86
Nov-1 22.30 22.93 23.11 22.05
Nov-4 22.75 24.36 24.95 22.52
Nov-5 21.62 23.93 24.79 21.46
Nov-6 26.00 26.62 27.30 25.24
Nov-7 26.56 26.09 27.17 25.60
Nov-8 25.88 27.06 27.38 25.68
Nov-11 27.58 30.38 32.29 27.50

Beam Therapeutics Earnings

Beam Therapeutics Earnings Report: Per Share Beam Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Beam Therapeutics Forecast Revenue Growth

Beam Therapeutics Stock Analysis: Historical quarterly revenues per share for Beam Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.58 per share, and a decrease next year of $0.04 per share.

* Beam Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.